Code | 2404A | ||||||||||
MA number | 44/0362/12-S | ||||||||||
Product Form: | tbl flm 240x500 mg (blis.Al/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 20.08.2012 |
SPC: | SPC_Capecitabine STADA_05.2024.pdf |
PIL: | PIL_Capecitabine STADA_05.2024.pdf |
Safety feature | Yes |
Data update: | 09.05.2024 |